Brink James A
Department of Diagnostic Radiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
J Comput Assist Tomogr. 2003 May-Jun;27 Suppl 1:S3-8. doi: 10.1097/00004728-200305001-00003.
Various complex pharmacokinetic interrelationships affect the use of contrast media for computed tomography (CT) imaging. These include factors related to each patient's unique body habitus and their degree of health, such as their age, gender, height, weight, and cardiovascular status. Of equal importance are factors related to the contrast material injection. The volume, concentration, and rate of injection all affect the degree of enhancement that is achieved with an injection of contrast material. In addition, the injection technique--whether the contrast is infused at a constant injection rate (uniphasic injection) or whether the rate is altered during the injection (multiphasic injection)--also affects the magnitude and duration of contrast enhancement. In body CT imaging, the liver poses unique challenges in managing the use of intravenous contrast material because of its dual blood supply and the need to complete imaging before equilibrium occurs between the intravascular and extravascular compartments. The magnitude of hepatic enhancement that is ultimately achieved is related primarily to the amount of iodinated contrast material that accumulates in the extravascular space within the target organ, independent of the speed of the CT scanner. The key determinant of the onset of the equilibrium phase is the injection duration. Given that a high injection flow rate (4-5 ml/s) is desirable for arterial phase imaging, the injection duration is maintained by using an appropriate contrast volume. Thus, modifications of the total iodine dose are best performed by altering the contrast concentration. Use of a high contrast concentration (400 mg iodine/ml) may be advantageous in heavy patients, or in patients in whom routine imaging is married with a need for high-detail imaging of the vasculature with high resolution CT angiography. The magnitude of arterial enhancement that is achieved is related to both the concentration of contrast and the rate of administration. The speed of the scanner determines its ability to record image data during the most advantageous time period, the peak of arterial enhancement. Thus, rapid imaging is particularly advantageous for optimal contrast use in CT angiography as well as in multiphasic imaging of the parenchymal organs.
多种复杂的药代动力学相互关系会影响用于计算机断层扫描(CT)成像的造影剂的使用。这些因素包括与每位患者独特的身体状况及其健康程度相关的因素,例如年龄、性别、身高、体重和心血管状况。与造影剂注射相关的因素同样重要。注射的体积、浓度和速率都会影响注射造影剂后所达到的增强程度。此外,注射技术——造影剂是按恒定注射速率注入(单相注射)还是在注射过程中改变速率(多相注射)——也会影响造影剂增强的幅度和持续时间。在体部CT成像中,肝脏在管理静脉造影剂的使用方面存在独特挑战,因为它有双重血液供应,并且需要在血管内和血管外间隙达到平衡之前完成成像。最终实现的肝脏增强幅度主要与积聚在目标器官血管外间隙中的碘化造影剂的量有关,与CT扫描仪的速度无关。平衡期开始的关键决定因素是注射持续时间。鉴于动脉期成像需要高注射流速(4 - 5毫升/秒),通过使用适当的造影剂体积来维持注射持续时间。因此,改变造影剂浓度是调整总碘剂量的最佳方法。对于肥胖患者或需要将常规成像与使用高分辨率CT血管造影对血管系统进行高细节成像相结合的患者,使用高浓度造影剂(400毫克碘/毫升)可能具有优势。所达到的动脉增强幅度与造影剂浓度和给药速率都有关。扫描仪的速度决定了它在最有利的时间段(动脉增强峰值)记录图像数据的能力。因此,快速成像对于CT血管造影以及实质器官的多相成像中最佳使用造影剂特别有利。